Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Apr 24, 2024

SELL
$1.16 - $2.23 $29,231 - $56,196
-25,200 Closed
0 $0
Q3 2021

Apr 24, 2024

BUY
$2.24 - $4.29 $22,400 - $42,900
10,000 Added 65.79%
25,200 $58 Million
Q1 2021

Apr 24, 2024

SELL
$4.39 - $9.08 $29,325 - $60,654
-6,680 Reduced 30.53%
15,200 $110 Million
Q4 2020

Apr 24, 2024

BUY
$3.86 - $5.07 $84,456 - $110,931
21,880 New
21,880 $94.5 Million

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Bulltick Wealth Management, LLC Portfolio

Follow Bulltick Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.